We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Name | Symbol | Market | Type |
|---|---|---|---|
| Merck KGaA (PK) | USOTC:MKKGY | OTCMarkets | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.02 | 0.06% | 33.31 | 32.87 | 34.09 | 33.64 | 33.29 | 33.4927 | 19,012 | 21:28:42 |
From Jun 2022 to Jun 2024
--A French subsidiary of pharmaceutical company Merck KGaA is facing further investigations in France for potentially misleading information related to a change in formula of its thyroid medication Levothyrox, news agency AFP reports.
--The unit said investigations aren't related to the quality of the new formula but communications related to the change in 2017, AFP reports.
--Shares in Merck KGaA are down 4% at EUR164.70.
Write to Kim Richters at kim.richters@wsj.com
(END) Dow Jones Newswires
October 19, 2022 05:17 ET (09:17 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
1 Year Merck KGaA (PK) Chart |
1 Month Merck KGaA (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
